Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · Real-Time Price · USD
1.160
-0.010 (-0.85%)
Nov 21, 2024, 3:47 PM EST - Market closed
Unity Biotechnology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 20 | 32 | 39 | 84 | 277 | 331 | |
| Market Cap Growth | -29.33% | -16.69% | -53.86% | -69.60% | -16.29% | -51.87% | |
| Enterprise Value | 15 | 14 | -14 | 57 | 209 | 211 | |
| Last Close Price | 1.17 | 1.93 | 2.74 | 14.60 | 52.40 | 72.10 | |
| PS Ratio | - | - | 164.78 | 17.62 | - | - | |
| PB Ratio | 1.39 | 1.14 | 0.69 | 1.41 | 3.35 | 2.74 | |
| P/TBV Ratio | 1.75 | 1.14 | 0.69 | 1.41 | 3.35 | 2.74 | |
| EV/Sales Ratio | - | - | - | 11.82 | - | - | |
| Debt / Equity Ratio | 1.73 | 0.95 | 0.90 | 0.96 | 0.77 | - | |
| Asset Turnover | - | - | 0.00 | 0.03 | - | - | |
| Quick Ratio | 3.31 | 5.71 | 4.84 | 5.30 | 6.76 | 7.41 | |
| Current Ratio | 3.45 | 5.94 | 4.92 | 5.45 | 6.97 | 7.52 | |
| Return on Equity (ROE) | -86.95% | -94.36% | -76.90% | -85.26% | -92.19% | -58.41% | |
| Return on Assets (ROA) | -30.34% | -25.30% | -27.94% | -25.20% | -37.12% | -34.20% | |
| Return on Capital (ROIC) | -34.44% | -29.69% | -31.20% | -26.95% | -42.75% | -40.42% | |
| Earnings Yield | -111.05% | -123.04% | -114.35% | -72.05% | -33.85% | -24.81% | |
| FCF Yield | -114.32% | -114.52% | -135.03% | -53.70% | -28.49% | -22.34% | |
| Buyback Yield / Dilution | -15.08% | -55.60% | -70.10% | -9.73% | -16.60% | -54.32% | |
| Total Shareholder Return | -15.08% | -55.60% | -70.10% | -9.73% | -16.60% | -54.32% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.